Covid19
India's Bharat Biotech submits data on COVID-19 drug trial in children | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3DCSBLCNZJLYLBSRFDJBIUCSLY.jpg)
BENGALURU, Oct 6 (Reuters) – Bharat Biotech said on Wednesday it had submitted data from its COVID-19 vaccine trial in children aged 2 to 18 years to …
BENGALURU, Oct 6 (Reuters) – Bharat Biotech said on Wednesday it had submitted data from its COVID-19 vaccine trial in children aged 2 to 18 years to …
